Learn more about the innovative light-based therapy for meibomian gland dysfunction (MGD).
The new OptiClear XL offers the benefits of Intense Pulsed Light (IPL) - the specialized light-based solution for the treatment of Meibomian Gland Dysfunction (MGD).
MGD is the leading cause of evaporative dry eye (Dry Eye Disease - DED), which affects millions of people around the world and can lead to chronic eye discomfort and inflammation.
​
Standard treatments such as anti-inflammatory drops, oral antibiotics and warm compresses provide only temporary relief or are completely ineffective.
MGD is associated with inflammation of the eyelids as well as several symptoms that can severely limit quality of life for patients. These include dryness, itching, red eyes, fatigue and, most importantly, blurred vision in many cases.
OptiClear XL is a breakthrough solution that targets the cause of DED, not just the symptoms. OptiClear XL is a gentle, non-invasive yet highly effective treatment that stimulates the meibomian glands while relieving vascular inflammation, providing long-term relief from meibomian gland dysfunction.
​
Clinical studies have shown that IPL (Intense Pulsed Light) treatment alleviates the symptoms of MDD and provides effective, long-term relief. OptiClear XL utilises light energy in a precise, narrow-band spectrum for this targeted therapeutic area.